Literature DB >> 8058048

Functional receptors in Xenopus oocytes for U-37883A, a novel ATP-sensitive K+ channel blocker: comparison with rat insulinoma cells.

E Guillemare1, E Honore, J De Weille, M Fosset, M Lazdunski, K Meisheri.   

Abstract

Follicle-enclosed Xenopus oocytes were used to describe the ATP-sensitive K+ (KATP) channel-blocking properties of U-37883A (4-morpholinecarboximidine-N-1-adamantyl-N'-cyclohexyl), in comparison with glibenclamide. In follicular oocytes, the KATP channel opener P1060 (30 microM), a pinacidil analog, activated a large outward K+ current that was blocked by glibenclamide (IC50 = 0.33 microM) and U-37883A (IC50 = 0.26 microM). P1060 activation was inhibited by both U-37883A and glibenclamide in a noncompetitive manner. U-37883A also blocked the KATP channel activation by cAMP (300 microM) and adenosine (10 microM). Single-channel studies on isolated follicular cells showed that U-37883A (10 microM) reduced the open probability of the KATP channel by 76%, without significantly modifying the single-channel current amplitude. Receptor binding studies with [3H]U-37883 in membranes from follicle-enclosed oocytes demonstrated a single class of low affinity binding sites, with a Kd of 450 nM and a Bmax of 17 pmol/mg of protein. Studies with analogs of U-37883A showed that U-52090A inhibited KATP current and displaced [3H]U-37883 from its binding site with similar potencies. In contrast, U-42069D neither inhibited KATP current nor competed with [3H]U-37883 binding. In RINm5F cells (an insulinoma cell line), U-37883A, unlike glibenclamide, failed to inhibit KATP current. Furthermore, there was no significant specific binding of [3H]U-37883 in RINm5F cell membranes, which displayed high levels of specific binding of [3H]glibenclamide. These data demonstrate the presence of a receptor for U-37883A-type guanidines that controls the activity of the endogenous KATP channels in follicle-enclosed oocytes. The available data collectively suggest that U-37883A is a more selective blocker of the follicular KATP channel, which is very similar to that in smooth muscle, than of the pancreatic beta cell KATP channel.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8058048

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  13 in total

1.  Eukaliuric diuresis and natriuresis in response to the KATP channel blocker U37883A: micropuncture studies on the tubular site of action.

Authors:  D Y Huang; H Osswald; V Vallon
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

2.  Inhibition of vascular K(ATP) channels by U-37883A: a comparison with cardiac and skeletal muscle.

Authors:  G C Wellman; R Barrett-Jolley; H Köppel; D Everitt; J M Quayle
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

3.  Molecular analysis of the subtype-selective inhibition of cloned KATP channels by PNU-37883A.

Authors:  H Kovalev; J M Quayle; T Kamishima; D Lodwick
Journal:  Br J Pharmacol       Date:  2004-02-02       Impact factor: 8.739

4.  Binding of [3H]-P1075, an opener of ATP-sensitive K+ channels, to rat glomerular preparations.

Authors:  F Metzger; U Quast
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-10       Impact factor: 3.000

Review 5.  ATP-sensitive K+ channels in the kidney.

Authors:  U Quast
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

Review 6.  ATP-regulated K+ channel in mitochondria: pharmacology and function.

Authors:  A Szewczyk; A Czyz; G Wojcik; L Wojtczak; M J Nalecz
Journal:  J Bioenerg Biomembr       Date:  1996-04       Impact factor: 2.945

Review 7.  The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives.

Authors:  Lukas Wanka; Khalid Iqbal; Peter R Schreiner
Journal:  Chem Rev       Date:  2013-02-25       Impact factor: 60.622

8.  Early increases in renal kallikrein secretion on administration of potassium or ATP-sensitive potassium channel blockers in rats.

Authors:  T Fujita; I Hayashi; Y Kumagai; N Inamura; M Majima
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

9.  Cocaine inhibits cromakalim-activated K+ currents in follicle-enclosed Xenopus oocytes.

Authors:  Murat Oz; Irina Zakharova; Meral Dinc; Toni Shippenberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-12-03       Impact factor: 3.000

10.  K(ATP) channel expression and pharmacological in vivo and in vitro studies of the K(ATP) channel blocker PNU-37883A in rat middle meningeal arteries.

Authors:  K B Ploug; L J Boni; M Baun; A Hay-Schmidt; J Olesen; I Jansen-Olesen
Journal:  Br J Pharmacol       Date:  2008-03-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.